November 29th, 2009
The European Medicines Agency (EMEA), European CDC, and the Heads of Medicines 
Agencies (HMA) established a document regarding the monitoring of the benefits and risks of H1N1 vacines in relation to the safety and effectivenes of the vaccines.
The document covers materials such as Influenza A (H1N1) vaccines safety and effectiveness, the immunogenicity, benefit-risk evaluation, vaccine manufacturers, the vaccines authorised, research, clinical and public health centres, components of strategies in monitoring the benefit-risk A/H1N1 vaccines, and the funding mechanisms in relation to the overall benefit-risk assesment.
Influenza A (H1N1) Vaccine Risk-Benefit Monitoring in Europe continued »
Filed in Swine Flu, Vaccine
- Tags: H1N1 Vaccine Europe, vaccine monitoring strategy
-
0 Comments
November 21st, 2009
Major mechanisms causing brain damage in stroke are described in the following article of Neurology. This article was 
written by Sid Shah, MD from the Foundation for Education and Research in Neurological Emergencies.
It covers materials such as Focal Ischemic Injury, Cerebral Blood Flow, Mechanisms of Neuronal Injury, Ischemic Penumbra, Neuronal Death, Ischemic Stroke, Thrombosis, Embolism, Global-Ischemic or Hypotensive Stroke, and Question and Answers in association with Pathophysiology of Stroke.
Neurology Article: The Pathophysiology of Stroke continued »
Filed in Stroke
- Tags: Neurology Article, stroke article, stroke pathophysiology
-
0 Comments
Agencies (HMA) established a document regarding the monitoring of the benefits and risks of H1N1 vacines in relation to the safety and effectivenes of the vaccines.
